Patents by Inventor Patricia M. Beckmann

Patricia M. Beckmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Organ-Specific Proteins and Methods of Their Use
    Publication number: 20140106981
    Abstract: The present invention relates generally to methods for identifying and using organ-specific proteins and transcripts. The present invention further provides compositions comprising organ-specific proteins and transcripts encoding the same, detection reagents for detecting such proteins and transcripts, and diagnostic panels, kits and arrays for measuring organ-specific proteins/transcripts in blood, biological tissue or other biological fluid.
    Type: Application
    Filed: November 5, 2013
    Publication date: April 17, 2014
    Applicants: Integrated Diagnostics, Inc., Institute for Systems Biology
    Inventors: Leroy Hood, Patricia M. Beckmann, Richard Johnson, Marcello Marelli, Xiaojun Li
  • Organ-specific proteins and methods of their use
    Patent number: 8586006
    Abstract: The present invention relates generally to methods for identifying and using organ-specific proteins and transcripts. The present invention further provides compositions comprising organ-specific proteins and transcripts encoding the same, detection reagents for detecting such proteins and transcripts, and diagnostic panels, kits and arrays for measuring organ-specific proteins/transcripts in blood, biological tissue or other biological fluid.
    Type: Grant
    Filed: August 9, 2007
    Date of Patent: November 19, 2013
    Assignees: Institute for Systems Biology, Integrated Diagnostics, Inc.
    Inventors: Leroy Hood, Patricia M. Beckmann, Richard Johnson, Marcello Marelli, Xiaojun Li
  • ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE
    Publication number: 20120087862
    Abstract: The present invention relates generally to methods for identifying and using organ-specific proteins and transcripts. The present invention further provides compositions comprising organ-specific proteins and transcripts encoding the same, detection reagents for detecting such proteins and transcripts, and diagnostic panels, kits and arrays for measuring organ-specific proteins/transcripts in blood, biological tissue or other biological fluid.
    Type: Application
    Filed: August 9, 2007
    Publication date: April 12, 2012
    Applicants: HOMESTEAD CLINICAL CORPORATION, INSTITUTE FOR SYSTEMS BIOLOGY
    Inventors: Leroy Hood, Patricia M. Beckmann, Richard Johnson, Marcello Marelli, Xiaojun Li
  • Human FLTS3 ligand
    Patent number: 6632424
    Abstract: Ligands for flt3 receptors capable of transducing self-renewal signals to regulate the growth, proliferation or differentiation of progenitor cells and stem cells are disclosed. The invention is directed to flt3-L as an isolated protein, the DNA encoding the flt3-L, host cells transfected with cDNAs encoding flt3-L, compositions comprising flt3-L, methods of improving gene transfer to a mammal using flt3-L, and methods of improving transplantations using flt3-L. Flt3 -L finds use in treating patients with anemia, AIDS and various cancers.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: October 14, 2003
    Assignee: Immunex Corporation
    Inventors: Stewart D. Lyman, Patricia M. Beckmann
  • Antibodies against flt3 ligand
    Patent number: 6630143
    Abstract: Ligands for flt3 receptors capable of transducing self-renewal signals to regulate the growth, proliferation or differentiation of progenitor cells and stem cells are disclosed. The invention is directed to anti-flt3-L antibodies and enzyme-linked immunosorbent assays comprising such antibodies.
    Type: Grant
    Filed: June 24, 1996
    Date of Patent: October 7, 2003
    Assignee: Immunex Corporation
    Inventors: Stewart D. Lyman, Patricia M. Beckmann
  • Antibodies immunoreactive with leukemia inhibitory factor receptors
    Patent number: 5785967
    Abstract: Leukemia inhibitory factor receptor (LIF-R) proteins, DNAs and expression vectors encoding LIF-R, and processes for producing LIF-R as products of recombinant cell culture, and antibodies that are immunoreactive with LIF-R are disclosed.
    Type: Grant
    Filed: November 29, 1994
    Date of Patent: July 28, 1998
    Assignee: Immunex Corporation
    Inventors: David P. Gearing, Patricia M. Beckmann
  • Leukemia inhibitory factor receptors and fusion proteins
    Patent number: 5420247
    Abstract: Leukemia inhibitory factor receptor (LIF-R) proteins, DNAs and expression vectors encoding LIF-R, and processes for producing LIF-R as products of recombinant cell culture, are disclosed.
    Type: Grant
    Filed: September 10, 1993
    Date of Patent: May 30, 1995
    Assignee: Immunex Corporation
    Inventors: David P. Gearing, Patricia M. Beckmann